Medical Condition News

RSS

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.

25 Aug 2010

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Total Nutraceutical Solutions, Inc., announced that it has completed a research study comparing the therapeutic effect of single nutrient forms of synthetic Vitamin D3 and D2 versus natural Vitamin D2 within a whole food. The study focused on the control of Paraquat induced oxidative stress/biologic death.

25 Aug 2010

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.

25 Aug 2010

MRI and MR spectroscopy determine internal fat distribution: Study

Why is it that some people lose weight and body fat when they exercise and eat less and others don't. German researchers say MRI and magnetic resonance (MR) spectroscopy can provide the answer and help predict who will benefit from lifestyle changes.

25 Aug 2010

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 data at this year's Joint International NGM Meeting on Saturday, August 28, 2010.

25 Aug 2010

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that some surveyed physicians indicate that they will decrease their overall prescribing of long-acting beta2 agonists (LABA)/inhaled corticosteroids (ICS) combination therapies over the next 12 months for the treatment of asthma in response to the U.S. Food and Drug Administration's new safety controls for LABA-containing medications.

25 Aug 2010

Northern Neurological Alliance launches website for patients with neurological conditions

The North East Neurological Partnership has launched a new website to support people living with neurological conditions.

25 Aug 2010

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA.

25 Aug 2010

HCM patients undergoing transplant can expect reasonable long-term survival rates: Research

Transplant surgery to correct the most common type of genetic heart disease yields similar short-term and potentially greater long-term survival rates as transplant surgery for other heart diseases, according to research reported in Circulation: Heart Failure, an American Heart Association journal.

25 Aug 2010

BIO president comments on U.S. District Court injunction on embryonic stem cell research funds

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research.

25 Aug 2010

New study finds walking, cycling results in lower levels of obesity and diabetes

Amble, stroll or pedal: it's all good. A new study provides evidence supporting a seemingly obvious − but unproven − link between walking- and cycling-friendly communities and lower levels of obesity.

25 Aug 2010

Reducing patient body temperature with cold salt beneficial for patients undergoing balloon angioplasty

Treating heart attack patients with hypothermia reduces the amount of heart damage by more than one third after balloon angioplasty. Researchers in Lund, Sweden have today released the results of a study showing that the amount of heart damage in heart attack patients whose body temperature was lower than 35˚C (95˚F) was reduced by more than one third after they were treated with balloon angioplasty to open their clogged heart vessel.

25 Aug 2010

Scientists discover Magnetic Resonance Spectroscopy can rapidly diagnose degenerative disorders

Magnetic Resonance Spectroscopy can distinguish between neurological diseases in patients without clear symptoms.A team of American scientists claim that a new method of testing for neurological diseases could provide doctors with a rapid and non-invasively method of diagnosing degenerative disorders.

25 Aug 2010

Insuring your health: Health law requires continued coverage for patients in clinical trials

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "When Richard Crusoe was diagnosed with a rare form of soft tissue cancer called liposarcoma, the retired firefighter and his family pinned their hopes of slowing the cancer's advance on a drug that was being tested in a clinical trial" (Andrews, 8/24).

25 Aug 2010

CAS researchers confirm Gleevec’s first generation drug targets chronic myelogenous leukemia

Today, leukemia patients who have struggled with cancer therapy resistance and intolerance will now have more options thanks to targeted drug therapy. Such new treatment options are due, in part, to a rapid increase in journal and patent publications following the discovery of Gleevec, as reported by Chemical Abstracts Service (CAS), the world's authority for chemical information.

25 Aug 2010

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Agilent Technologies Inc.today introduced the SureSelect Human All Exon v2 Target Enrichment kit, which was developed in close collaboration with the Broad Institute of MIT and Harvard. The kit, the 15th SureSelect product in Agilent's portfolio, is a single tube assay that allows researchers to streamline experiments by sequencing the expressed genome while discarding regions not of interest.

25 Aug 2010

Researchers identify specific gene responsible for Kuf's disease

A North Carolina State University researcher has helped to locate and identify a gene responsible for a fatal neurodegenerative disease that affects American Staffordshire terriers. This same gene may be responsible for a similar rare, fatal disease in humans. Its discovery will lead to improved screening and diagnosis of the disease in dogs and is the first step in working toward a cure for both canines and humans.

25 Aug 2010

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.

25 Aug 2010

Fluoridation exposure during childhood prevents adult tooth loss

Children drinking water with added fluoride helps dental health in adulthood decades later, a new study finds.

25 Aug 2010

Two diabetes medications increase risk of heart attack, failure: Study

In contrast to previous reports, the risks of the composite endpoint of heart attack, heart failure, both, or death were the same about 4 percent for patients taking the diabetes drugs rosiglitazone or pioglitazone, according to a study published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

25 Aug 2010

Medical Condition News

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

MRI and MR spectroscopy determine internal fat distribution: Study

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Physicians decrease LABA/ICS combination therapy for asthma treatment: Survey

Northern Neurological Alliance launches website for patients with neurological conditions

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

HCM patients undergoing transplant can expect reasonable long-term survival rates: Research

BIO president comments on U.S. District Court injunction on embryonic stem cell research funds

New study finds walking, cycling results in lower levels of obesity and diabetes

Reducing patient body temperature with cold salt beneficial for patients undergoing balloon angioplasty

Scientists discover Magnetic Resonance Spectroscopy can rapidly diagnose degenerative disorders

Insuring your health: Health law requires continued coverage for patients in clinical trials

CAS researchers confirm Gleevec’s first generation drug targets chronic myelogenous leukemia

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Researchers identify specific gene responsible for Kuf's disease

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

Fluoridation exposure during childhood prevents adult tooth loss

Two diabetes medications increase risk of heart attack, failure: Study

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News